456 related articles for article (PubMed ID: 26514292)
1. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.
He H; Sun L; Ye J; Liu E; Chen S; Liang Q; Shin MC; Yang VC
J Control Release; 2016 Oct; 240():67-76. PubMed ID: 26514292
[TBL] [Abstract][Full Text] [Related]
2. Cell-penetrating peptides: strategies for anticancer treatment.
Raucher D; Ryu JS
Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
[TBL] [Abstract][Full Text] [Related]
3. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
4. 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting.
Ye J; Shin MC; Liang Q; He H; Yang VC
J Control Release; 2015 May; 205():58-69. PubMed ID: 25483423
[TBL] [Abstract][Full Text] [Related]
5. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
Feni L; Neundorf I
Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
[TBL] [Abstract][Full Text] [Related]
6. CPP-Assisted Intracellular Drug Delivery, What Is Next?
Ye J; Liu E; Yu Z; Pei X; Chen S; Zhang P; Shin MC; Gong J; He H; Yang VC
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854260
[TBL] [Abstract][Full Text] [Related]
7. [The application of enzyme-sensitive activatable cell-penetrating peptides to targeted delivery system].
He F; Cao L; Zhang XJ; Xiang B; Cao DY; Qi XR
Yao Xue Xue Bao; 2015 Feb; 50(2):141-7. PubMed ID: 25975019
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
[TBL] [Abstract][Full Text] [Related]
9. Improved Protein Toxin Delivery Based on ATTEMPTS Systems.
Chen Y; Zhang M; Min KA; Wang H; Shin MC; Li F; Yang VC; Huang Y
Curr Drug Targets; 2018 Feb; 19(4):380-392. PubMed ID: 28260497
[TBL] [Abstract][Full Text] [Related]
10. Activatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drug.
Xia H; Gu G; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Song Q; Yao L; Tu Y; Chen H; Gao X; Chen J
Bioconjug Chem; 2013 Mar; 24(3):419-30. PubMed ID: 23350619
[TBL] [Abstract][Full Text] [Related]
11. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide.
Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I
Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977
[TBL] [Abstract][Full Text] [Related]
12. Recent advances of anti-cancer therapies including the use of cell-penetrating peptides.
Klimpel A; Lützenburg T; Neundorf I
Curr Opin Pharmacol; 2019 Aug; 47():8-13. PubMed ID: 30771730
[TBL] [Abstract][Full Text] [Related]
13. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
Lin W; Xie X; Yang Y; Fu X; Liu H; Yang Y; Deng J
Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.
Lin W; Xie X; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
J Drug Target; 2016; 24(2):134-46. PubMed ID: 26176270
[TBL] [Abstract][Full Text] [Related]
15. Smart Cell-Penetrating Peptide-Based Techniques for Intracellular Delivery of Therapeutic Macromolecules.
He Y; Li F; Huang Y
Adv Protein Chem Struct Biol; 2018; 112():183-220. PubMed ID: 29680237
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
[TBL] [Abstract][Full Text] [Related]
17. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier.
Yang Y; Yang Y; Xie X; Cai X; Mei X
J Drug Target; 2014 Dec; 22(10):891-900. PubMed ID: 25045925
[TBL] [Abstract][Full Text] [Related]
19. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
20. Cell-penetrating peptides in protein mimicry and cancer therapeutics.
Zorko M; Jones S; Langel Ü
Adv Drug Deliv Rev; 2022 Jan; 180():114044. PubMed ID: 34774552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
